This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nexbiome Therapeutics. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Vincent Mazel: Innovator in Mucoadhesive Drug Delivery Systems
Introduction
Vincent Mazel is a notable inventor based in Mérignac, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of drug delivery systems. His innovative work focuses on enhancing the effectiveness of medications through advanced formulations.
Latest Patents
Vincent Mazel holds a patent for a mucoadhesive sustained-release vaginal tablet. This invention includes at least one probiotic strain of the genus compressed with an excipient suitable for conferring upon the tablet the properties of vaginal wall mucoadhesion and sustained release. This patent represents a significant advancement in the field of women's health and drug delivery.
Career Highlights
Mazel is currently associated with Nexbiome Therapeutics, a company dedicated to developing innovative therapeutic solutions. His work at Nexbiome Therapeutics has allowed him to explore new frontiers in drug formulation and delivery.
Collaborations
Vincent collaborates with talented professionals in his field, including Claudia Thoral and Pierre Tchoreloff. These collaborations enhance the research and development efforts at Nexbiome Therapeutics.
Conclusion
Vincent Mazel's contributions to the field of mucoadhesive drug delivery systems highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to pave the way for advancements in pharmaceutical technology.